A detailed history of Bay Colony Advisory Group, Inc D transactions in Neuronetics, Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 16,210 shares of STIM stock, worth $69,865. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,210
Holding current value
$69,865
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$1.49 - $5.54 $24,152 - $89,803
16,210 New
16,210 $59,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $116M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.